pcn poster

Posters

Is Increased Severity of Major Depressive Disorder Associated With Incremental Economic Burden in Privately Insured US Patients With Treatment Resistant Depression?

Background: Among patients with major depressive disorder (MDD), those with treatment-resistant depression (TRD) have a higher economic burden. However, healthcare resource utilization (H...

Laura Morrison , MPH;

Patrick Lefebvre , MA;

John J. Sheehan , PhD, MBA, RPh;

Dominic Pilon , MA;

Kruti Joshi , MPH, MD;

Holly Szukis , MPH;

Maryia Zhdanava , MA;

03/01/2019

Improvements in At-Home Functional Impairment With DR/ER-MPH in Children With Attention-Deficit/Hyperactivity Disorder (ADHD): Post Hoc Analysis of BSFQ and PREMB-R by Norm-Referenced Cut-Offs

Background: Age-adjusted cut-offs for two scales of ADHD-related at-home functional impairment, the Before School Functioning Questionnaire (BSFQ) and the Parent Rating of Evening and Mor...

Steven Pliszka , MD;

F. Randy Sallee , MD, PhD;

Jeffrey Newcorn , MD;

Stephen V. Faraone , PhD;

Norberto DeSousa , MA;

Timothy Wilens , MD;

Bev Incledon , PhD;

03/01/2019

Formulation Properties of Long-Acting Injectable Antipsychotics and the Impact on Administration: Focus on Aripiprazole Lauroxil

Background: Long-acting injectable (LAI) antipsychotics have significant differences in formulation composition, which is an important factor for administration technique. Here, we review...

03/01/2019

Factors Associated With Treatment Initiation With Atypical Long-acting Injectable Antipsychotics Among Medicaid Patients With Schizophrenia

Objectives: Investigate demographic, clinical, and economic factors associated with treatment initiation of paliperidone palmitate (PP) and aripiprazole LAI (ALAI) in Medicaid patients wi...

Antoine C. El Khoury , PhD;

Charmi Patel , BS , RN, BSN, MPH;

Nancy Connolly , MPH;

Edward Kim , MD, MBA;

Qian Cai , MSPH, MS;

Ozgur Tunceli , PhD;

03/01/2019

Exploring the Differences in Empathy Towards Patients With Mental Illness Between Second-, Third- and Fourth-Year Medical Students

Previous studies have shown a general decline in students' empathy as they advance through the years of medical school. However, to my knowledge, there have not been studies evaluating di...

Michellee Mayers , BA;

Frank H. Netter , MD;

Ilene Rosenberg , MD;

03/01/2019

Evaluating Pharmacotherapies for Postpartum Depression: A Comparison of SSRIs to Brexanolone Injection, A Novel Investigational Compound

Objective: In randomized controlled trials (RCTs) in women with postpartum depression (PPD), 60 hours of continuous brexanolone infusion (90mg/kg) was associated with significant reductio...

Miranda Cooper , MSc, BSc;

Hannah Kilvert , MSc;

Adi Eldar-Lissai , PhD;

Paul Hodgkins , PhD, MSc;

Neil Roskell , MSc;

03/01/2019

Esketamine Nasal Spray Tolerability Trends During Post-Dose Monitoring in Patients With Treatment-Resistant Depression

Objective: This post hoc analysis assessed (1) whether the first-week incidence of adverse events (AEs) considered most commonly linked to the duration of the post-dose monitoring period ...

Mary Petrillo , PharmD;

Jagadish Gogate , PhD;

H. Lynn Starr , MD, FAAP;

Jennifer Kern Sliwa , PharmD, BCPP;

Ella Daly , MB, BCh, BAO;

David Williamson , PhD, MBA;

Lewis Manera , MS;

03/01/2019

Esketamine Nasal Spray Combined With an Oral Antidepressant for Relapse Prevention in Treatment-Resistant Depression: Results of a Double-Blind, Randomized Withdrawal, Multicenter Study (SUSTAIN-1)

Background: Numerous studies have demonstrated short-term efficacy of esketamine in treatment-resistant depression (TRD), whereas long-term antidepressant effects remain to be established...

John Zajecka , MD;

Madhukar Trivedi , MD;

Andrew Winokur , MD, PhD;

Wayne Drevets , MD;

Ilona Divacka , MBA, MD;

Jaskaran Singh , MD;

Andrea Fagiolini , MD;

Wieslaw Cubala , MD, PhD;

Xiang Li , PhD;

Pierre Blier , MD, PhD;

Rosanne Lane , MD, MSc, MS;

Richard Shelton , MD;

Pilar Lim , MD, PhD;

Patricio Molero , MD, PhD;

David Hough , MD;

Husseini Manji , MD;

Istvan Bitter , MD, PhD, DSc;

Adam Janik , MD;

Michael Thase , MD;

Honglan Li , MD, PhD;

Yun Zhang , PhD;

Anna Ducca , BSN;

Ella Daly , MB, BCh, BAO;

03/01/2019

Enhancing the Treatment of MDD Through an Interprofessional Educational Activity

Introduction: The goal of this interprofessional continuing education (IPCE) activity was to enhance the treatment of major depressive disorder (MDD) using patient cases.

Jess Dropkin ;

Roger McIntyre , MD, FRCPC;

Jovana Lubarda , PhD;

Marcello Morgan , MD, MPH;

03/01/2019

Encounters With the Criminal Justice System in Patients With Schizophrenia or Schizoaffective Disorders Treated With Long Acting Therapy at a Community Mental Health Service Facility

Purpose: This study assessed the association between the use of Long-acting injectable (LAI) anti-psychotic drugs and encounters with the criminal justice system (CJS) among patients rece...

Madhav Bhatta , PhD;

Saroj Bista , BPharm;

Antoine C. El Khoury , PhD;

Eric Hutzell , MPH;

Douglas Smith , MD;

Neeta Tandon , MA;

03/01/2019

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

Posters

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products